Logo

Fluxergy: Ali Tinazli

Oct 15, 2019

Fluxergy, an Irvine, California-based developer of point-of-care diagnostics systems, has appointed Ali Tinazli as chief commercial officer. Tinazli joins Fluxergy from Hewlett-Packard, where he led corporate-wide global strategy for healthcare and life sciences. He has also worked in corporate development at Applied Biosystems (now Thermo Fisher Scientific). He also worked for Sony where he helped build a healthcare consumables business that was acquired by Stratec.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.